Art

J-GLOBAL ID：201902277048987751   Reference number：19A1569076

Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats

ガスミスト発生器を用いた経皮的二酸化炭素治療はモノクロタリン誘発肺高血圧ラットにおける右心室機能不全の程度を軽減する

Author (9)： YAMAGUCHI Takehiro (Osaka City Univ., Osaka, JPN) ,  IZUMI Yasukatsu (Osaka City Univ., Osaka, JPN) ,  YAMAZAKI Takanori (Asakayama General Hospital) ,  NAKAMURA Yasuhiro (Izumi Municipal Hospital) ,  SANO Soichi (Osaka City Univ., Osaka, JPN) ,  SHIOTA Masayuki (Osaka City Univ., Osaka, JPN) ,  MIURA Katsuyuki (Osaka City Univ., Osaka, JPN) ,  IWAO Hiroshi (Shitennouji Univ.) ,  YOSHIYAMA Minoru (Osaka City Univ., Osaka, JPN)
Material： Osaka City Medical Journal  (Osaka City Med J)
Volume： 61  Issue： 1  Page： 31-41  Publication year： Jun. 2015 
JST Material Number： F0951A  ISSN： 0030-6096  CODEN： OCMJA  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： rat ,...
Semi thesaurus term： *Ventricular Dysfunction, Right ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1569076&from=J-GLOBAL&jstjournalNo=F0951A") }}

JST classification (2)： Basic medicine on cardiovascular system  (GJ01020K) ,  Heart  (EJ04020D)

Reference (38)：

• McLaughlin VV. Looking to the future: a new decade of pulmonary arterial hypertension therapy. Eur Respir Rev 2011;20:262-269.
• Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-117.
• Anand SS, Yusuf S, Pogue J, Weitz JI, Flather M. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results. Circulation 1998;98:1064-1070.
• Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000;132:425-434.
• Nakamura A, Nagaya N, Obata H, Sakai K, Sakai Y, Yoshikawa M, et al. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. Circ J 2013;77:2127-2133.

Terms in the title (9)： ミスト発生器 ,  二酸化炭素 ,  治療 ,  モノクロタリン ,  誘発 ,  肺高血圧 ,  ラット ,  右心室機能不全 ,  程度